AGENCY AGREEMENTAgency Agreement • July 14th, 2009 • IntelGenx Technologies Corp. • Pharmaceutical preparations • Ontario
The undersigned, Paradigm Capital Inc., Bolder Investment Partners, Ltd. and Union Securities Ltd. (collectively, the “Agents”), understand that IntelGenx Technologies Corp. (the “Company”) proposes to issue and sell, subject to requisite regulatory approval, up to 15,000,000 special warrants (individually a “Special Warrant” and, collectively, the “Special Warrants”) having the terms described herein, at a price of C$0.40 per Special Warrant (the “Issue Price”) for aggregate gross proceeds to the Company of up to C$6,000,000. The offering of Special Warrants is hereinafter referred to as the “Offering”. Each Special Warrant shall entitle the holder thereof to acquire for no additional consideration or further action on the part of the holder, and subject to adjustment in certain circumstances as set out in the Special Warrant Certificate (as hereinafter defined), one unit of the Company (a “Unit”) on the Automatic Exercise Date (as hereinafter defined), provided that in the event that
SUBSCRIPTION AGREEMENT – SPECIAL WARRANTS AMONG INTELGENX TECHNOLOGIES CORP. AND SYNDICATE OF AGENTS REPRESENTED BY PARADIGM CAPITAL INC. AND THE UNDERSIGNED SUBSCRIBERSubscription Agreement • July 14th, 2009 • IntelGenx Technologies Corp. • Pharmaceutical preparations • Ontario
Private Placement of up to 11,250,000 special warrants at $0.40 per special warrant. Each special warrant will entitle the holder to acquire, for no further consideration and subject to adjustment as set out herein, one unit of IntelGenx Technologies Corp. Each unit will consist of one common share and one common share purchase warrant. Each common share purchase warrant will entitle the holder to purchase one common share of IntelGenx Technologies Corp. for 36 months following the closing of the offering at an exercise price of US$0.80.
INTELGENX TECHNOLOGIES CORP. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 14th, 2009 • IntelGenx Technologies Corp. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of the 13th day of July, 2009 between IntelGenx Technologies Corp., a Delaware corporation (the “Company”), and Paradigm Capital Inc., Bolder Investment Partners, Ltd. and Union Securities Ltd. (collectively, the “Agents”).
